Vaxil Bio Financial Overview
Vaxil Bio's market cap is currently C$356.14K. The company's EPS TTM is C$-0.007; its P/E ratio is -5.10; Vaxil Bio is scheduled to report earnings on November 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
